help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chamoux, E.
Right arrow Articles by Gallo-Payet, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chamoux, E.
Right arrow Articles by Gallo-Payet, N.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 5 2090-2098
Copyright © 2001 by The Endocrine Society


Original Studies

Identification of Extracellular Matrix Components and Their Integrin Receptors in the Human Fetal Adrenal Gland1

Estelle Chamoux, Louis Bolduc, Jean-Guy Lehoux2 and Nicole Gallo-Payet

Service of Endocrinology (E.C., L.B., N.G.-P.), Department of Biochemistry (J.-G.L.), Faculty of Medicine, University of Sherbrooke, Sherbrooke, Québec, Canada J1H 5N4

Address all correspondence and requests for reprints to: Dr. Nicole Gallo-Payet, Service of Endocrinology, Faculty of Medicine, University of Sherbrooke, 3001 12th Avenue North, Sherbrooke, Québec, Canada J1H 5N4. E-mail: n.gallo{at}courrier.usherb.ca


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The development of the human fetal adrenal gland is characterized by a gradient of mitotic activity, cell migration, and cell apoptosis, all of which dictate its particular function. Such plasticity may possibly be under the control of the extracellular environment. The goal of this study was to identify components of the extracellular matrix in second-trimester fetal adrenal glands. Whereas collagen IV was expressed evenly throughout the gland, both fibronectin and laminin demonstrated a mirror-imaged distribution, with higher expression of fibronectin in the central portion and laminin at the periphery of the gland. The integrin subunit {alpha}1 was found mainly in the definitive zone and the {alpha}2-subunit mainly in the transitional zone, whereas integrin {alpha}3 (which binds both fibronectin and laminin) was detected only in the fetal zone. The ß2-subunit was observed solely in chromaffin cells. Such specific gradients of integrin and MEC component expression suggest that the extracellular environment does play a definite role during adrenal gland development. Indeed, compared with that in untreated plastic dishes, ACTH stimulation of dehydroepiandrosterone sulfate and cortisol was enhanced by collagen IV. In addition, fibronectin enhanced dehydroepiandrosterone sulfate but decreased cortisol secretion, compared with collagen IV substrates. These results provide fundamental insight into the contribution of the microenvironment in cellular processes leading to fetal adrenal gland development.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE HUMAN FETAL adrenal gland follows a developmental pattern that is very different from that of other nonprimate species. Indeed, in contrast to the well-known divisions in the adult gland (zona glomerulosa, zona fasciculata, zona reticularis), the adrenal cortex, from the second trimester of gestation, is divided into two zones: at the periphery, the definitive zone, which is mainly proliferative; and the fetal zone, largely steroidogenic, which represents 85% of the whole gland. This fetal zone is composed of large cells secreting dehydroepiandrosterone sulfate (DHEAS) (for review, see 1, 2). The currently proposed theory to explain the zonation of the developing adrenal cortex (2) is similar to the migration theory of cell renewal in the adult adrenal gland (3): cells proliferate in the external portion of the definitive zone, then, as a result of mitotic pressure, are driven to centripetal migration (4) and become nonproliferative in the fetal zone, where they acquire steroidogenic capacities. On reaching the central portion of the gland, they undergo programmed cell death (5, 6). In parallel, pheochromoblasts, originating from the neural crest, begin migration throughout the fetal cortex, as early as 6 weeks of pregnancy (7, 8). Paracrine action of steroids from the fetal cells induce their progressive differentiation into chromaffin cells (9). At the end of the second trimester, a third region, called transitional zone, appears between the definitive and fetal zones, where cells exhibit an intermediate phenotype of that found in each of the adjacent zones. This region is considered as a progenitor of the adult zona fasciculata; whereas the fetal zone will involute, inducing a dramatic decrease in the volume of the neonatal gland (1, 2).

This particular morphological developmental pattern, observed in primate fetal adrenal glands, is tightly associated with its functional development and properties (2). Because the fetal zone primarily expresses the enzyme P450C17, steroidogenesis is oriented toward DHEAS production (10). On approaching term, the transitional zone progressively becomes immunoreactive for 3ß-hydroxysteroid dehydrogenase (3ß-HSD) and begins to produce cortisol (11). In summary, fetal adrenal gland maturation in humans involves zone-regulated proliferation, differentiation, and apoptosis, together with zone-regulated expression of steroidogenic enzymes, as well as migration from the periphery to the central portion of the gland.

Several studies indicate that the extracellular microenvironment can orchestrate functions such as proliferation, migration, differentiation (12, 13, 14), and even anoikis (15). These observations suggest that the extracellular matrix (ECM) and its receptors, integrins, could play an important role during fetal development (16) and in tissue remodeling (17). However, there is little data concerning cellular functions associated with expression of ECM components and integrins in the adrenal gland. The only available studies involve expression of some ECM substrates and thrombospondins in the bovine adult adrenal cortex. As reviewed recently by Feige et al. (18), a differential expression of fibronectin and laminin is observed from the periphery to the center of the gland, which is associated with cell-specific activities. For example, laminin stimulates chemotaxis and haptotaxis of adrenocortical cells (19), whereas a cocktail of various ECM components (Matrigel) potentiates hormone-stimulated expression of the steroidogenic enzymes (20).

The aim of the present study was thus to identify and localize some of the most common ECM components, namely laminin, fibronectin, and the nonfibrillar collagen IV, as well as some of their receptors of the integrin family, in the intact human fetal adrenal gland. These results should provide fundamental insight into the contribution of the microenvironment in cellular processes leading to fetal adrenal development.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Chemicals (reagents)

The chemicals used in the present study were obtained from the following sources: Tissue-Tek embedding medium for frozen tissue specimens from Miles (Elkhart, IN); gelatin from Fisher Scientific(Nepean, Ontario, Canada). Primary antibodies used in this work were monoclonal antibodies directed against human collagen IV, chromogranin A, and human {alpha}- and ß-integrin screening kits (ECM430 and ECM440, respectively), all from Chemicon (Temecula, CA), as well as fibronectin (clone FN15) from Sigma-Aldrich Corp. (Oakville, Ontario, Canada). An antilaminin rabbit polyclonal antibody (Sigma-Aldrich Corp.) was also used. Vectashield mounting medium was from Vector Laboratories, Inc. (Burlingame, CA); fluorescein isothiocyanate (FITC)-conjugated antimouse or antirabbit antibodies, from Roche Molecular Biochemicals (Montréal, Québec, Canada). Deoxyribonuclease was purchased from Sigma (St. Louis, MO) and collagenase, MEM-Eagle-Medium, and OPTI-MEM from Life Technologies, Inc. (Burlington, Ontario, Canada). Matrix-coated dishes (collagen IV, fibronectin, laminin) were from BD-VWR Canlab (Ville Mont-Royal, Québec, Canada). Anticortisol antibody for RIA was from ICN Biochemicals, Inc. (Costa Mesa, CA); antidehydroepiandrosterone (DHEA) and antidehydroepiandrosterone sulfate (DHEAS) antibody were kindly provided by Dr. Alain Bélanger (Laboratoire d’Endocrinologie Moléculaire, Center de recherche du CHUL, Ste-Foy, Québec, Canada). Tritiated cortisol was from Amersham Pharmacia Biotech (Oakville, Ontario, Canada); tritiated DHEA and DHEAS were from NEN Life Science Products-DuPont (Missauga, Ontario, Canada). ACTH 1–24 peptide (Cortrosyn) was from Organon (Toronto, Ontario, Canada), and angiotensin (Ang) II was from Bachem California, Inc. (Marina Delphen, CA). All other chemicals were of A-grade purity.

Retrieval and preparation of glands

Fetal adrenal glands were obtained from fetuses between 14 and 21 weeks old (post fertilization) at the time of therapeutic abortion. Fetal ages were estimated by foot length and time after last menstruation, according to Streeter et al. (21). The project was approved by the human subject review committee of our institution. After retrieval, glands were cleansed of fat in MEM and were either processed immediately for cellular preparation or were included in a cryoprotectant (OCT Tissue Tek), frozen in liquid nitrogen, and stored at -80 C until use. Sections of 3–5 µm were prepared and used for immunofluorescence detection.

Immunofluorescence studies

Tissue sections were processed according to the method of Basora et al. (22). In brief, sections were fixed in 100% cold ethanol for 10 min at -20 C and then progressively rehydrated with successive Hanks’ buffer saline (HBS: 130 mM NaCl, 3.5 mM KCl, 1.8 mM MgCl2 2.5 mM NaHCO3, and 5 mM HEPES) washings. Autofluorescence was prevented by incubating sections in glycine (0.01 M) in HBS for 30 min. Nonspecific sites were blocked with 10% nonfat milk for 30 min. The sections were then incubated with the primary antibody either directed against laminin (dilution 1:100), fibronectin (dilution 1:500), collagen IV (dilution 1:500), or different {alpha}- and ß-integrin subunits (dilution 1:250), for 1 h at room temperature, in a humidified atmosphere. After washings with HBS, the sections were incubated with the secondary FITC-coupled antibody (either antimouse, antirabbit, or antirat) in a blocking solution containing 0.05% BSA, for 1 h at room temperature, in a humidified atmosphere. After washing, sections were stained with a 0.01% Evan’s Blue solution, which allows visualization of the cellular composition of the whole gland when examined with a rhodamine filter. After two subsequent washings, slides were mounted with Vectashield mounting medium and examined under a fluorescence microscope [Leica Corp. (Québec, Canada) Reichart Polyvar 2 or Nikon (Missauga, Ontario, Canada) Ellipse 300] equipped with B-1E FITC and G-2A rhodamine specific filters. In all cases, no specific staining was observed when primary antibodies were replaced by rabbit preimmune serum (data not shown). Note that the illustrations (except one, see Fig. 3CGo) were taken with the same camera settings for contrast and brightness.



View larger version (79K):
[in this window]
[in a new window]
 
Figure 3. Immunodetection of laminin in the human fetal adrenal gland. Slides were stained, as described in Fig. 1Go, with an antihuman laminin antibody (1:100). A, Whole fetal cortex (bar, 100 µm); B, DZ and TZ; C, FZ (bars, 25 µm). Laminin is detected at the periphery of the gland, in the capsule, and in the transitional zone. Arrow, A small artery at the periphery. Scattered expression is also observed in the fetal zone. Filled arrows, High intensity labeling; open arrow, labeling around small artery.

 
Measurement of steroid secretions

Glands were processed as described previously (5, 23). Whole tissues were used for cell preparation, without separation of fetal zone, neocortex, or chromaffin cells. Briefly, small pieces of tissue (1–2 mm3) were dissociated with collagenase (2 mg/mL) and deoxyribonuclease (25 µg/mL) in Eagle’s MEM containing 2% antibiotics. After three incubation periods of 20 min, cells were dissociated, filtered, and centrifuged for 10 min at 100 x g. The cell pellet was suspended in OPTI-MEM medium containing 2% FCS and antibiotics. Cells were plated at a density of about 1 x 105 in 35 mm, either on plastic Petri dishes or in dishes coated with various matrices including collagen IV, fibronectin, or laminin. Cells were grown for 3 days in a humidified atmosphere of 95% air-5% CO2, at 37 C, and either stimulated with ACTH (10-9 M) or vehicle every 24 h after an initial 24-h resting period. The culture medium was collected every 24 h and stored at -20 C until assayed for steroid secretion. DHEA, DHEAS, and cortisol were determined by RIA using specific antisera and tritiated steroid as tracer. The data are presented as means ± SEM from three independent fetuses. Statistical P values were obtained from Dunnett’s tables, using the Bartlett’s test.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Collagen IV, fibronectin, and laminin immunolocalization

Cryo-sections from second-trimester adrenal glands were used to immunolocalize the most common components of the ECM, i.e. collagens, fibronectin, and laminin. Each of these glycoproteins comprises a large family of proteins, collagen I being common to all tissues and collagen IV found in the basement membranes of epithelial cells (24, 25). We used antibodies raised against the common portion of each of the proteins to be tested. Type IV collagen was present, exhibiting the same level of expression throughout the gland (Fig. 1AGo). Labeling was found in the capsule and in large arrays penetrating the neocortex and the adjacent fetal zone. Labeling was also visible as fibrillar structures underlining sinusoid and capillaries (Fig. 1BGo), as shown by the corresponding pattern of localization of the von Willerbrand factor (a marker of endothelial cells) (Fig. 1CGo). Moreover, a very low level of expression was found around each cell of the definitive zone (Fig. 1BGo). In the fetal zone, labeling changed progressively from large ribs in the external portion [Fig. 1Go, D (open arrow) and E] to a more specific localization around each cell (arrow) in the center of the gland (Fig. 1Go, F and G). Fibronectin was also detected, but the overall pattern of expression was higher in the central portion of the gland, compared with the periphery (Fig. 2AGo). Fibers were found in the capsule and as columns penetrating the definitive zone and the adjacent fetal zone (Fig. 2BGo). Some weak labeling could be seen around small groups of neocortical cells (Fig. 2BGo); whereas, deeper in the gland, each cell was clearly surrounded by fibronectin (Fig. 2CGo, arrow). Laminin was also detected in the fetal adrenal gland; however, the overall labeling is low, compared with collagen or fibronectin (Fig. 3AGo, arrow). The highest labeling is observed around small arteries in the capsule (Fig. 3BGo) and around each cell of the transitional zone (Fig. 3Go, A and B). When pictures of the fetal zone were analyzed with high magnification (Fig. 3CGo), a tiny labeling was also shown around each fetal cell, along with a strong labeling at some points (arrows), which could be focal adhesions or capillaries. Indeed, this micrograph was taken with optimized camera settings because of the low level of laminin expression in the fetal zone.



View larger version (155K):
[in this window]
[in a new window]
 
Figure 1. Immunodetection of type IV collagen in the human fetal adrenal gland. Frozen sections (3–5 µm) of an 18-week-old human fetus were processed for immunofluorescence labeling using a primary antibody directed against human collagen IV (1:500). After a 2-h incubation at room temperature, slides were washed in HBS and incubated, for 1 h at room temperature, with an antirabbit FITC-coupled antibody. Before the final washing, slides were counterstained with Evan’s Blue. A, Whole fetal cortex (bar, 100 µm); B, definitive zone (DZ); C, immunofluorescent detection of vWF factor; D and E, transitional zone (TZ), immunolabeling (D), and Evan’s Blue labeling (E); F and G, fetal zone (FZ), immunolabeling (F), and Evan’s Blue labeling (G). Bars, 25 µm. Collagen IV is equally expressed throughout the fetal cortex. The capsule is intensely labeled, and weak signal can be observed around cells of the definitive zone. Cells of the fetal zone are also surrounded by collagen IV. Filled arrows, Labeling around each cell; open arrow, labeling around each cluster of cells.

 


View larger version (145K):
[in this window]
[in a new window]
 
Figure 2. Immunodetection of fibronectin in the human fetal adrenal cortex. Slides were stained, as described in Fig. 1Go, with an antihuman fibronectin antibody (1:500). A, Whole fetal cortex (bar, 100 µm); B, DZ; C, FZ (bars, 25 µm). Fibronectin labeling is detected in the capsule, between cell groups of the transitional zone and, more intensely, in the deep fetal zone. Open arrows, Labeling around each cell.

 
Integrin immunolocalization

Because ECM components bind to integrins to generate intracellular signals, we then examined whether the most common candidates for fibronectin, laminin, and collagen binding could be detected in the human fetal adrenal gland. All integrins are dimers of {alpha}- and ß-chains, with the ß1-subunit being the most common (12, 13). Thus, ß1 could be considered as being ubiquitous. As expected, all areas of the fetal adrenal gland were immunopositive for the integrin subunit ß1, including small arteries in the capsule (Fig. 4AGo, arrow). The ß1-chain was expressed uniformly over cells of the definitive zone (Fig. 4AGo) and of the fetal zone (Fig. 4BGo). Specific ß2 labeling was also localized in the capsule and in islets of small cells (Fig. 5Go, A and C) dispersed throughout the fetal cortex, with a higher concentration in the central portion of the gland (Fig. 5AGo). Labeling of consecutive sections with chromogranin A (a marker for secretory granules of chromaffin cells, Fig. 5Go, B and D) confirmed the localization of the ß2-integrin on chromaffin cells (Fig. 5Go, A and C).



View larger version (127K):
[in this window]
[in a new window]
 
Figure 4. Immunodetection of the integrin subunit ß1 in the human fetal adrenal. Slides were stained, as described in Fig. 1Go, with an antihuman ß1-integrin subunit antibody (1:250). A, DZ; B, FZ. Bars, 25 µm. ß1-subunit is found in all fetal adrenal zones, including small arteries present under the capsule (arrow).

 


View larger version (103K):
[in this window]
[in a new window]
 
Figure 5. Immunodetection of the integrin subunit ß2 in chromaffin cells. Serial sections were stained, as described in Fig. 1Go, either with an antihuman ß2-integrin subunit antibody (1:500, A and B) or with an antichromogranin A antibody (1:100, C and D). A and C, Whole fetal cortex (bar, 100 µm) including the DZ and FZ zones; B and D, isolated groups of immunopositive cells (bar, 25 µm). Small groups of immunopositive cells are found dispersed in the fetal zone and identified as chromaffin cell (CC) islets with chromogranin A labeling in a serial section. Higher magnification confirmed the identity of these cells, islets being immunopositive for ß2-subunit and chromogranin A. Arrows, Chromaffin cells in the fetal zone.

 
The integrin subunit {alpha}1 was present throughout the fetal adrenal cortex, following a gradient of expression that was higher in the definitive zone (Fig. 6AGo). Labeling seemed to be localized at the surface of each cell from the definitive (Fig. 6BGo), fetal zone (Fig. 6CGo) and chromaffin cells (Fig. 6DGo). Integrin {alpha}2 was detected in both definitive and fetal zones (Fig. 7AGo), with a labeling higher in the transitional zone (Fig. 7BGo) and around fetal cells (Fig. 7CGo). In contrast, the {alpha}3-chain was absent in the definitive zone, despite a clear signal in the capsule (Fig. 8AGo), but was present in the fetal zone, with a more intense expression at the center (Fig. 8BGo).



View larger version (89K):
[in this window]
[in a new window]
 
Figure 6. Immunodetection of the integrin subunit {alpha}1 in the whole fetal adrenal cortex. Slides were stained, as described in Fig. 1Go, with an antihuman {alpha}1-integrin subunit antibody (1:250). A, Whole fetal cortex (bar, 100 µm); B, DZ; C, FZ; D, CC (bar, 25 µm). {alpha}1 is expressed throughout the fetal adrenal gland, including chromaffin cells. Labeling is more intense in the definitive zone.

 


View larger version (158K):
[in this window]
[in a new window]
 
Figure 7. Immunodetection of the {alpha}2-integrin subunit in the fetal adrenal cortex. Slides were stained, as described in Fig. 1Go, with an antihuman {alpha}2-integrin subunit antibody (1:250). A, Whole fetal cortex (bar, 100 µm); B, DZ; C, FZ (bar, 25 µm). The entire fetal cortex is immunopositive for {alpha}2, although the transitional zone seems to be more intensely labeled than cells from the definitive zone and fetal zones.

 


View larger version (110K):
[in this window]
[in a new window]
 
Figure 8. immunodetection of the {alpha}3-integrin subunit in the fetal adrenal gland. Slides were stained, as described in Fig. 1Go, with an antihuman {alpha}3-integrin subunit antibody (1:250). A, DZ; B, FZ (bar, 25 µm). Despite a tight signal in the capsule, {alpha}3 seems to be absent in the definitive zone but is expressed in the fetal zone.

 
Steroid secretion on defined matrix

To assess whether the distribution pattern of matrix and receptors had a specific physiological significance, we measured DHEA, DHEAS, and cortisol production by fetal adrenal cells cultured on various matrices. Under control conditions, all of the substrates tested (collagen IV, fibronectin, and laminin) enhanced the basal level of C19-steroid secretion during the first 24 h of culture (data not shown). After a 24-h resting period, cells were stimulated with ACTH every 24 h for 2 days. As shown in Fig. 9AGo, the three matrices did not modify significantly ACTH-stimulated DHEA secretion, compared with plastic Petri dishes. In contrast, after 48 h of ACTH stimulation, DHEAS and cortisol secretions were enhanced in cultures on collagen IV (Fig. 9Go, B and C). Moreover, on fibronectin matrix, ACTH-stimulated DHEAS was increased (Fig. 9BGo), although cortisol stimulation was decreased (Fig. 9CGo).



View larger version (23K):
[in this window]
[in a new window]
 
Figure 9. Measurement of fetal adrenal gland steroids produced by cells cultured on various ECM components. Cells were cultured for 3 days on plastic-coated Petri dishes (P1), collagen type IV (CIV), fibronectin (FN), or laminin (LN) in the absence (open bar) or in the presence of 10-9 M ACTH (hatched bar). After 3 days, the medium was collected; and DHEA (A), DHEAS (B), and cortisol (C) were measured by RIA. Results (mean ± SE of three independent fetuses) are expressed as a ratio of ACTH-stimulated cells vs. control. *, P = 0.05, fibronectin vs. plastic-coated dishes.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
This study reveals that several ECM components, namely collagen IV, fibronectin, and laminin, are expressed in the human fetal adrenal gland. Whereas collagen IV was evenly distributed throughout the gland, both fibronectin and laminin showed a mirror-image distribution, with expression of fibronectin higher in the center of the gland, whereas that of laminin was higher at the periphery. We also show expression of integrin subunits ß1, {alpha}1, and {alpha}2 distributed throughout the gland, whereas ß2 and {alpha}3 had a more restricted pattern of expression.

Specific cellular responses are mediated by the recruitment of multiple cytoskeleton-associated proteins activated by binding of ECM components to their receptors, integrins (12, 13, 14). Most integrins recognize several ECM proteins; and these proteins, such as fibronectin, laminin, and collagens, can bind to several integrins (12, 13, 14). In the human fetal gland from the second trimester of gestation, we were able to identify collagen IV, the main component of basement membranes (24); fibronectin, a major protein involved in cell adhesion; and laminin, mainly implicated in migration. In addition to strong labeling in the capsule, collagen IV underlined capillaries and sinusoids, exhibiting a radial disposition and surrounding small groups of cells. This localization of collagen IV in basement membranes is compatible with the migration en masse of the medulla toward the central portion of the gland, recently reviewed by Wolkersdorfer et al. (26). As in the adult bovine adrenal gland (18), fibronectin was more abundant in the center than in the periphery, indicating that the gradient for fibronectin expression takes place early in gestation. The expression pattern of laminin was noticeably different from that seen for fibronectin and collagen IV. Stronger labeling was seen at the periphery, although some scattered labeling was also observed deeper in the gland. These observations are different from those of Pellerin et al. (19), who described a uniform distribution of laminin throughout the cortex of the bovine adrenal gland. For Pellerin et al., fibronectin and laminin are equally potent in promoting haptotaxis, suggesting that these molecules could drive cell migration from the periphery toward the center. Altogether, the most noticeable difference among collagen IV, fibronectin, and laminin was their gradient of expression from the periphery to the central region of the gland. All of these growth factors have been detected in the human fetal adrenal gland and shown to be involved in steroidogenesis (2).

From a hormonal point of view, some studies have shown that adrenocortical stimuli have opposite effects on fibronectin and laminin expression. ACTH and Ang II increase the synthesis of laminin (with ACTH being the most potent), whereas transforming growth factor ß (TGFß), fibroblast growth factor 2 (FGF-2), and insulin-like growth factor I decrease synthesis (19). The opposite was observed with fibronectin, whereby expression was stimulated by TGFß, FGF-2, and insulin-like growth factor I but decreased with ACTH and Ang II. However, in the adult cardiac tissue, several studies indicate that Ang II strongly stimulates MEC expression, in particular fibronectin and collagen (27, 28).

As mentioned previously, integrins comprise a large family of proteins composed of two subunits, {alpha} and ß, and each {alpha}ß combination has its own MEC binding specificity and signaling properties. We identified the {alpha}1- and {alpha}2-subunits, as well as the ß1-subunits, in the whole fetal adrenal gland. The overall pattern of expression for the ß1-chain is not surprising, considering the involvement of this chain in a wide range of {alpha}/ß-dimers. Indeed, the ß1 cytoplasmic domain is essential for integrin localization to sites of focal contacts, essential for cell adhesion and required for survival. In contrast, deletion of the {alpha}-subunit decreases cell adhesion or cell motility, indicating that specificity in cell function is associated with the {alpha}-subunit (13, 29). The integrins {alpha}1ß1 and {alpha}2ß1 are both high-affinity receptors for collagen IV (30). We found {alpha}1 mostly in the definitive zone and {alpha}2 mainly in the transitional zone. Together with the pattern observed for collagen IV, the localization of {alpha}1, {alpha}2, and ß1 is again consistent with a possible role in adhesion and migration (31, 32), both of which are active processes during adrenal gland development. Recent studies have shown that activation of {alpha}1ß1 after collagen/laminin binding mediates cell contraction (32, 33), a process which could contribute to migration. In addition, although collagen and laminin are equally recognized by {alpha}2ß1, this association does not lead to cell contraction, as observed with {alpha}1ß1, whereas both integrins are involved in adhesion/migration (33). Furthermore, in addition to migration, {alpha}2ß1 may induce apoptosis, at least in T lymphocytes (34). The differential expression of {alpha}1ß1 and {alpha}2ß1 may thus reflect a functional difference between definitive and transitional zones.

The other two {alpha}- and ß-subunits detected revealed a more specific pattern of expression. Indeed, the {alpha}3-integrin subunit was not detected in the definitive zone but was present in the fetal zone. According to Kühn and Eble (30) and Arregui et al. (35), this {alpha}-chain, in association with the ß1-subunit, is a weak affinity receptor for fibronectin. Considering the fact that {alpha}5- and {alpha}4-subunits, both high-affinity receptors for fibronectin when associated with ß1 (30), failed to be identified in the fetal adrenal gland, {alpha}3ß1 could be considered as the fibronectin receptor in the fetal zone, where laminin is poorly expressed. The expression of a weak-affinity receptor for fibronectin ({alpha}3ß1) is in agreement with the model of cell migration proposed for fetal adrenal gland development, more than a strong adhesive complex such as {alpha}5ß1 with fibronectin (1, 2).

As stated previously, Ang II and TGFß modulate ECM composition, not only in the adrenal gland but also in cardiac and vascular tissues (27, 36). In addition, TGFß can up-regulate {alpha}1ß1-expression (32, 37), and actions of Ang II can be modulated by matrix/receptors interactions (38). Moreover, glucocorticoids decrease the expression of {alpha}2- and ß1-subunits (39). Observations in adult tissues suggest that such hormonal control may occur in both fetal and chromaffin cells of the human fetal adrenal gland, where receptors are present. In regard to our previous results indicating that the AT2 receptor of Ang II is highly expressed in the fetal zone during the second trimester of gestation (23), a putative cross-talk between fibronectin/{alpha}3ß1/Ang II could be hypothesized. Some studies have demonstrated interactions between fibronectin and Ang II (38) that, as well as growth factors, share common signaling pathways with integrins (MAP kinases, Phospho Inositol-3 Kinase) (40) and can also induce cytoskeletal reorganization (5, 41, 42).

Interestingly, we also found a specific expression of the ß2-integrin subunit in chromaffin cells. These observations are the first to identify this subunit outside the lymphoid system. Indeed, this subunit has been extensively studied in hematopoietic cells and has been shown to be involved in migration and diapedesis of lymphocytes and leukocytes (43, 44). Considering that this integrin subunit is involved in migration and invasive processes, this subunit could play a role in the migration of chromaffin cells from the neural crest through the fetal cortex to colonize the center of the gland leading to the formation of the medulla.

In summary, we have identified {alpha}1-, {alpha}2-, and ß1-integrin subunits throughout the fetal adrenal cortex, and these integrins recognize collagen IV, fibronectin, and laminin. The gradient of fibronectin is more important in the central portion of the gland than at the periphery, whereas the opposite is true for laminin. We also identified the integrin {alpha}3 (which can bind fibronectin) only in the fetal zone, and ß2-integrin subunit solely in chromaffin cells.

This specific cell type expression, together with the gradient of expression of MEC components, strongly suggests that cellular environment plays a definite role during adrenal gland development. This hypothesis is supported by results on steroid secretion. During the second trimester of gestation, DHEAS is the major steroid produced by the human fetal adrenal gland. At this stage, cortisol is produced only marginally, using progesterone from the placenta rather than its own precursors (for review, see 2). In fact, 3ß-HSD, the limiting steroidogenic enzyme for cortisol production, is low or absent in the fetal cortex, whereas the other enzymes required for steroidogenesis are present in the fetal cortex. Previous studies have shown that ACTH induces the expression of 3ß-HSD in fetal adrenal cells cultured on plastic Petri dishes. These cells were thus able to produce cortisol (45). In the present study, we showed that cultures on fibronectin increased ACTH-stimulated DHEAS, but decreased that of cortisol, compared with collagen IV- or plastic-coated dishes. In addition, collagen IV, which is present throughout the gland, potentiates DHEAS and cortisol secretion by cells cultured in the presence of ACTH. Considering the expression pattern of fibronectin and {alpha}3-subunits, together with the well-accepted absence of 3ß-HSD in the fetal zone, we can hypothesize that environmental cues are involved in enzymatic expression. Corroborating these results, Cheng and Hornsby (20) have shown that Matrigel can promote P450 11ß-hydroxylase and P450 21-hydroxylase expression, which otherwise decreases on long-term culture.

Figure 10Go summarizes the present data, in keeping with the particular morphology and functional activity of the human fetal adrenal gland. There is no doubt that much work remains to be done, with regard to the relationships between MEC components and expression of steroidogenic enzymes. However, the present data opens the door to a novel issue in the field of hormone action and coupling in the adrenal gland. Specific characteristics of cell functions associated with these MEC and their respective integrins remain to be investigated, together with the modulation of their synthesis by ACTH, Ang II, or growth factors. The role of Ang II will be of particular interest because, during the second trimester of gestation, the expression of the AT2 receptor is predominant over that of AT1.



View larger version (79K):
[in this window]
[in a new window]
 
Figure 10. Summary of the differential distribution of ECM components (ECM) and their integrin receptors in the human fetal adrenal gland. Correlation with known steroid production. A, Micrograph of an hematoxylin-eosin-stained fetal adrenal gland showing the three morphologically discernible zones (definitive, transitional, and fetal), along with their respective steroid products, during the course of pregnancy. B, Expression of the MEC and integrins components, where intensity of shading correlates with the gradient of expression; collagen IV is distributed evenly throughout the fetal gland, whereas laminin is predominant in the definitive zone, and fibronectin is predominant in the fetal zone. Also shown are the relative abundance of the {alpha}- and ß-subunits of integrins detected in glands from the second trimester of gestation. Finally, the ß2-integrin subunit was detected in chromaffin cells.

 


    Acknowledgments
 
We thank Lucie Chouinard for her experimental assistance, and Jérome Boudet for his participation as a summer student. We are greatly indebted to Dr. Jean-François Beaulieu for fruitful advice and discussions, as well as for use of the cryostat and Leica Corp. microscope.


    Footnotes
 
1 This work was supported by grants from the Medical Research Council of Canada [to N.G.P. and J.-G.L. (MOP-37891)]. Back

2 A chercheur-boursier de carrière of FRSQ. Back

Received October 5, 2000.

Revised January 19, 2001.

Accepted January 24, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Winter J. 1992 Fetal and neonatal adrenocortical development. In: James V, ed. The adrenal cortex. New York: Raven Press; 87–104.
  2. Mesiano S, Jaffe RB. 1997 Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev. 18:378–401.[Abstract/Free Full Text]
  3. NussDorfer G. 1986 Cytophysiology of the adrenal cortex. Rev Cytol. 98:211–249.
  4. Vinson G, Ho M, Puddefoot J. 1998 Adrenocortical zonation and the adrenal renin-angiotensin system. Endocr Res. 24:677–686.[Medline]
  5. Chamoux E, Breault L, LeHoux J-G, Gallo-Payet N. 1999 Involvement of the angiotensin II type 2 receptor in apoptosis during human fetal adrenal development. J Clin Endocrinol Metab. 84:4722–4730.[Abstract/Free Full Text]
  6. Spencer S, Mesiano S, Lee J, Jaffe R. 1999 Proliferation and apoptosis in the human adrenal cortex during the fetal and perinatal periods: implications for growth and remodeling. J Clin Endocrinol Metab. 84:1110–1115.[Abstract/Free Full Text]
  7. Bocian-Sobkowska J, Wozniak W, Malendowicz L, Ginda W. 1996 Stereology of human fetal adrenal medulla. Histol Histopathol. 11:389–393.[Medline]
  8. Ehrhart-Bornstein M, Breidert M, Guadanucci P et al. 1997 17a-Hydroxylase and chromogranin A in 6th week human fetal adrenals. Horm Metab Res. 29:30–32.[Medline]
  9. Michelsohn A, Anderson D. 1992 Changes in competence determines the timing of two sequential glucocorticoid effects of sympathoadrenal progenitors. Neuron. 8:589–604.[CrossRef][Medline]
  10. Nelson H, Kuhn R, Deyman M, Jaffe R. 1990 Human fetal adrenal definitive and fetal zone metabolism of pregnenolone and corticosterone: alternate biosynthetic pathways and absence of detectable aldosterone synthesis. J Clin Endocrinol Metab. 70:693–698.[Abstract]
  11. Coulter C, Goldsmith P, Mesiano S, et al. 1996 Functional maturation of the primate fetal adrenal in vivo: 2. Ontogeny of corticosteroid synthesis is dependent upon specific zonal expression of 3ß-hydroxysteroid dehydrogenase/isomerase (3ß-HSD). Endocrinology. 137:4953–4959.[Abstract]
  12. Meredith JJ, Winitz S, Lewis J, et al. 1996 The regulation of growth and intracellular signaling by integrins. Endocr Rev. 17:207–220.[CrossRef][Medline]
  13. Aplin A, Howe A, Alahari S, Juliano R. 1998 Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev. 50:197–263.[Abstract/Free Full Text]
  14. Giancotti F, Ruoslahti E. 1999 Integrin signaling. Science. 285:1028–1032.[Abstract/Free Full Text]
  15. Frisch S, Francis H. 1994 Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 124:619–626.[Abstract/Free Full Text]
  16. Adams J, Watt F. 1993 Regulation of development and differentiation by the extracellular matrix. Development. 117:1183–1198.[Medline]
  17. Quaranta V, Plopper G. 1997 Integrins and laminins in tissue remodeling. Kidney Int. 51:1441–1446.[Medline]
  18. Feige J, Keramidas M, Chambaz E. 1998 Hormonally regulated components of the adrenocortical cell environment and the control of adrenal cortex homeostasis. Horm Metab Res. 30:421–425.[Medline]
  19. Pellerin S, Keramidas M, Chambaz E, Feige J. 1997 Expression of laminin and its possible role in adrenal cortex homeostasis. Endocrinology. 138:1321–1327.[Abstract/Free Full Text]
  20. Cheng C, Hornsby P. 1992 Expression of 11ß-hydroxylase and 21-hydroxylase in long-term cultures of bovine adrenocortical cells requires extracellular matrix factors. Endocrinology. 130:2883–2889.[Abstract]
  21. Streeter G. 1920 Weight, sitting height, head size, foot length and menstrual age of the human embryo. Contr Embryol. 11:143–179.
  22. Basora N, Vachon P, Herring-Gillam F, Perreault N, Beaulieu J. 1997 Relation between integrin {alpha}7Bß1 expression in human intestinal cells and enterocytic differentiation. Gastroenterology. 113:1510–1521.[CrossRef][Medline]
  23. Breault L, LeHoux JG, Gallo-Payet, N. 1996 The angiotensin AT2 receptor is present in the human fetal adrenal gland throughout the second trimester of gestation. J Clin Endocrinol Metab. 81:3914–3922.[Abstract/Free Full Text]
  24. Prockop D, Kivirikko K. 1995 Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem. 64:403–434.[CrossRef][Medline]
  25. Romberger D. 1997 Fibronectin. Int J Biochem Cell Biol. 29:939–943.[CrossRef][Medline]
  26. Wolkersdorfer G, Bornstein S. 1998 Tissue remodelling in the adrenal gland. Biochem Pharmacol. 56:163–171.[CrossRef][Medline]
  27. Hahn A, Regenass S, Kern F, Buhler F, Resink T. 1993 Expression of soluble and insoluble fibronectin in rat aorta: effects of angiotensin II and endothelin-1. Biochem Biophys Res Commun. 192:189–197.[CrossRef][Medline]
  28. Hsueh W, Do Y, Jeyaseelan R. 1998 Angiotensin II and cardiac remodeling. Mt Sinai J Med. 65:104–107.[Medline]
  29. Gullberg D, Ekblom P. 1995 Extracellular matrix and its receptors during development. Int J Dev Biol. 39:845–854.[Medline]
  30. Kühn K, Eble J. 1994 The structural bases of integrin-ligand interactions. Trends Cell Biol. 4:256–261.[CrossRef][Medline]
  31. Desban N, Duband J. 1997 Avian neural crest cell migration on laminin: interaction of the alpha1beta1 integrin with distinct laminin-1 domains mediates different adhesive responses. J Cell Sci. 110:2729–2744.[Abstract]
  32. Kagami S, Kondo S, Loster K, et al. 1999 {alpha}1ß1 integrin-mediated collagen matrix remodeling by rat mesangial cells is differentially regulated by transforming growth factor-ß and platelet-derived growth factor-BB. J Am Soc Nephrol. 10:779–789.[Abstract/Free Full Text]
  33. Gotwals P, Chi-Rosso G, Lindner V, et al. 1996 The {alpha}1ß1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization. J Clin Invest. 97:2469–2477.[Medline]
  34. Aoudjit F, Vuori K. 2000 Engagement of the {alpha}2ß1 integrin inhibits Fas ligand expression and activation-induced cell death in T cells in a focal adhesion kinase-dependent manner. Blood. 95:2044–2051.[Abstract/Free Full Text]
  35. Arregui C, Carbonetto S, McKerracher L. 1994 Characterization of neural cell adhesion sites: point contacts are the sites of interaction between integrins and the cytoskeleton in PC12 cells. J Neurosci. 14:6967–6977.[Abstract]
  36. Brilla C, Scheer C, Rupp H. 1997 Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism. J Hypertens Suppl. 15:S13–S19.
  37. Stewart H, Turner D, Jessen K, Mirsky R. 1997 Expression and regulation of alpha1beta1 integrin in Schwann cells. J Neurobiol. 33:914–928.[CrossRef][Medline]
  38. Schnapp L, Goswami S, Rienzi N, Koteliansky V, Gotwals P, Schachter E. 1998 Integrins inhibit angiotensin II-induced contraction in rat aortic rings. Regul Pept. 77:177–183.[CrossRef][Medline]
  39. Ryu J, Majeska R, Ma Y, LaChapelle L, Guller S. 1999 Steroid regulation of human placental integrins: suppression of {alpha}2-integrin expression in cytotrophoblasts by glucocorticoids. Endocrinology. 140:3904–3908.[Abstract/Free Full Text]
  40. Smith R, Baukal A, Dent P, Catt K. 1999 Raf-1 kinase activation by angiotensin II in adrenal glomerulosa cells: roles of Gi, phosphatidylinositol 3-kinase, and Ca2+ influx. Endocrinology. 140:1385–1391.[Abstract/Free Full Text]
  41. Côté M, Payet MD, Dufour MN, Guillon G, Gallo-Payet N. 1997 Association of the G protein {alpha}q/{alpha}11-subunit with cytoskeleton in adrenal glomerulosa cells: role in receptor-effector coupling. Endocrinology. 138:3299–3307.[Abstract/Free Full Text]
  42. Côté M, Payet M-D, Gallo-Payet N. 1997 Role of microtubules and microfilaments during ACTH stimulation in rat adrenal glomerulosa cells. Endocrinology. 138:69–78.[Abstract/Free Full Text]
  43. McGilvray I, Lu Z, Wei A, Rotstein O. 1998 MAP-kinase dependent induction of monocytic procoagulant activity by ß2-integrins. J Surg Res. 80:272–279.[CrossRef][Medline]
  44. Li X, Miyasaka M, Issekutz T. 1998 Blood monocyte migration to acute lung inflammation involves both CD11/CD18 and very late activation antigen-4-dependent and independent pathways. J Immunol. 161:6258–6264.[Abstract/Free Full Text]
  45. Mesiano S, Coulter C, Jaffe R. 1993 Localization of cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17{alpha}-hydroxylase/17, 20-lyase, and 3ß-hydroxysteroid dehydrogenase isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: reappraisal of functional zonation. J Clin Endocrinol Metab. 77:1184–1189.[Abstract]



This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
H. Ishimoto, D. G. Ginzinger, T. Matsumoto, Y. Hattori, M. Furuya, K. Minegishi, M. Tanaka, Y. Yoshimura, and R. B. Jaffe
Differential Zonal Expression and Adrenocorticotropin Regulation of Secreted Protein Acidic and Rich in Cysteine (SPARC), a Matricellular Protein, in the Midgestation Human Fetal Adrenal Gland: Implications for Adrenal Development
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3208 - 3214.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M.-C. Battista, M. Otis, M. Cote, A. Laforest, M. Peter, E. Lalli, and N. Gallo-Payet
Extracellular Matrix and Hormones Modulate DAX-1 Localization in the Human Fetal Adrenal Gland
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5426 - 5431.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Virtanen, M. Korhonen, N. Petajaniemi, T. Karhunen, L.-E. Thornell, L. M. Sorokin, and Y. T. Konttinen
Laminin Isoforms in Fetal and Adult Human Adrenal Cortex
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4960 - 4966.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Campbell, M. Otis, M. Cote, N. Gallo-Payet, and M. D. Payet
Connection between Integrins and Cell Activation in Rat Adrenal Glomerulosa Cells: A Role for Arg-Gly-Asp Peptide in the Activation of the p42/p44mapk Pathway and Intracellular Calcium
Endocrinology, April 1, 2003; 144(4): 1486 - 1495.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Chamoux, A. Narcy, J.-G. Lehoux, and N. Gallo-Payet
Fibronectin, Laminin, and Collagen IV as Modulators of Cell Behavior during Adrenal Gland Development in the Human Fetus
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1819 - 1828.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chamoux, E.
Right arrow Articles by Gallo-Payet, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chamoux, E.
Right arrow Articles by Gallo-Payet, N.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals